This study was a one-armed, observational, randomized, cross-over, single-site clinical trial. It was conducted by the orthopedic anesthesia department at the university hospital in Dresden, Germany, in February 2011. The study was approved by the local ethics committee (Ethikkommission der Medizinischen Fakultät Carl Gustav Carus, University Dresden) as an amendment to study EK375122009.
Six patients scheduled for elective leg surgery under general anesthesia were enrolled in the study after successful screening by the anesthesia team and after obtaining a written informed consent. The exclusion criteria were contraindications to the drugs used for anesthesia, pregnancy or breastfeeding, severe cardiac or pulmonary comorbidities (defined as the American Society of Anesthesiologists physical status III or greater), and contraindications to a laryngeal mask airway (LMA) or EIT. A flowchart of the study protocol is represented in
Figure 1.
All patients completed the study. Analysis was performed based on intention to treat. SB: Spontaneous breathing, PCV: Pressure controlled ventilation, PSV: Pressure support ventilation, Vt: tidal volume, RR: Respiratory rate, LMA: Laryngeal mask, PACU: Post anesthesia care unit.
After arrival in the operating room, the electrode belt of the EIT device (EIT Evaluation Kit 2, Drager Medical, Lubeck, Germany) was placed around the patient’s chest at the level of sixth intercostal space. The patients were connected to a monitoring system (Philips MP70, Philips Deutschland GmbH, Hamburg, Germany) for monitoring according to clinical standards (heart rate, noninvasive blood pressure and oxygen saturation). Baseline values were recorded while the patient was in supine, leveled position, breathing spontaneously without supplemental oxygen administration (time point AWAKE). For consistency, data of consecutive time points were recorded in leveled, supine position.
The anesthetic regimen was identical to the one we used in the previous study (
9). Prior to anesthesia induction, each patient received 2 mg midazolam. After anesthesia induction with sufentanil (0.1 µg/kg) and propofol (1 - 2 mg/kg), a LMA was placed and the cuff minimally inflated to achieve a seal up to 20 mbar. The patients were connected to a ventilator (ZEUS, Drager Medical). Ventilation data (respiratory rate, tidal volume, end-tidal carbon dioxide, volatile anesthetics, oxygen concentration, airway pressures and pressure curves) were recorded from the ZEUS ventilator using its MEDIBUS interface (MedLink, Nortis Ingenieurbüro, Lübeck, Germany).
All patients were ventilated in pressure support mode. The inspiratory pressure was adjusted to achieve a tidal volume of 6 - 8 mL/kg with no mandatory respiratory rate. Inspired fraction of oxygen (FiO2) was set to 0.8, no PEEP was used. Anesthesia was maintained with 0.7 MAC sevoflurane and repeated boluses of 0.1 µg/kg sufentanil according to the patients' clinical needs (defined as: respiratory rate > 10/minute, BIS > 60, tachycardia/hypertension or patient movement). Nitrous oxide was not used.
After an equilibration period of 10 minutes after insertion of LMA, the PSV-trigger was adjusted in a randomized sequence (computer generated randomization list for each individual patient) of the following settings: 2, 4, 6, 8, 10 and 15 L/minute (time points PSV 2 through PSV 15) or spontaneous breathing with no pressure support (time point SB). Each setting was maintained for at least three minutes while recording EIT data. We had previously observed that in patients with healthy lungs, changes in the mode of ventilation cause a redistribution of ventilation within only 2 - 4 breaths. We therefore concluded that an equilibration period of three minutes would be sufficient to achieve stable conditions for EIT measurements.
For each setting, we analyzed a sample of 5 - 6 consecutive breaths from the last minute. Software developed by the authors analyzed the distribution of ventilation-induced impedance changes and calculated the mean center of ventilation (COV). The center of ventilation (COV) is a single number with good reproducibility (
12), designed to simplify compare EIT recordings. A value of 50 indicates that the ventilation is equally distributed between the ventral and dorsal halves of the thorax. Higher numbers indicate a shift towards the ventral region and lower numbers indicate a shift towards the dorsum. Thus, the COV is a robust parameter which can be analyzed by statistical methods. The algorithms used for the analysis were identical to the ones used in the previous study (
9).
To analyze the distribution of ventilation by region of interest (ROI), the functional EIT image was divided into four stacked regions, each covering 25% of the ventrodorsal diameter, a common way of analyzing EIT images (
Figure 2). We added the impedance changes of all EIT pixels per ROI and divided the sum by the total sum of impedance changes in the entire functional EIT image, resulting in the fraction of the total tidal variation per ROI (given in %). An increase in the fractional tidal variation per ROI indicates a redistribution of ventilation towards this ROI.
The stacked bars illustrate changes in the ventilation distribution across the four regions of interest (ROI; the EIT image similar to a CT slice, as if viewing it from the patient’s feet looking into the direction of the patient’s head). The ventilation is similarly configured during Awake and SB. During PSV, we observed a ventral shift in the ventilation, indicated by an increase in ventilation in ROI 3 and 4 and a decrease in ROI 2 (P < 0.05; MANCOVA with a Sidak adjustment). There was no difference between various trigger sensitivity settings.
To further elucidate changes in distribution of ventilation occurring during inspiration, we calculated the regional intratidal gas distribution (ITV-Analysis) based on a method published by Lowhagen et al. (
14). The inspiration was divided into eight parts of equal impedance change, and for each of these eight parts, the relative proportion of impedance change in each of the four ROIs was calculated.
3.1. Statistics
The primary outcome in this study was increase in COV during PSV at different trigger levels. In our previous study, we found an effect size of 1.82 for the difference in COV comparing SB and PSV. Based on this finding, we calculated a sample size of six patients to achieve a power of 90% with an α-error of 5% (G * Power 3.1.2 by F. Faul (
15)).
Data was analyzed by multivariate analyses of variance with Sidak alpha adjustments, using the baseline values as a covariate (multivariate analysis of covariance (MANCOVA); PASW statistics release 17.0.2, SPSS Inc., Chicago, IL). This software was also used to generate the randomization list.